Should Radical Hysterectomy Be Aborted on Intraoperative Detection of Nodal Tumor Metastasis in Early Stage Cervical Cancer?

被引:5
作者
Garg, Gunjal [1 ,3 ]
Shah, Jay P. [2 ]
Liu, J. Rebecca [3 ]
机构
[1] Detroit Med Ctr, Dept Obstet & Gynecol, Detroit, MI USA
[2] Wayne State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Detroit, MI USA
[3] Univ Michigan, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA
关键词
radical hysterectomy; nodal metastasis; early stage cervical cancer; abort; GYNECOLOGIC-ONCOLOGY-GROUP; BULKY RESIDUAL DISEASE; RADIATION-THERAPY; POSTOPERATIVE RADIATION; PELVIC LYMPHADENECTOMY; SURGICAL-TREATMENT; RANDOMIZED-TRIAL; LYMPH-NODES; STAGES IB; CARCINOMA;
D O I
10.1097/LGT.0b013e3181e31e5d
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background/Objectives. In the United States, type 1 to 3 radical hysterectomy (RH) is used for the treatment of early stage (I-IIA) cervical cancer (ESCC). In the event that nodal metastasis is detected intraoperatively, completion of the procedure is controversial. Here, we present a review of the literature regarding clinical management of patients with ESCC with intraoperative diagnosis of nodal metastasis. Materials and Methods. An electronic search of PubMed and OVID for the English-language literature published between 1980 and 2008 was performed. Studies regarding completion or abandonment of RH on intraoperative detection of nodal metastasis in ESCC were reviewed to evaluate the impact of either approach on overall survival, recurrence rate, and complication rate. Results. This review was unable to document a difference in overall survival greater than 10% between the aborted and completed RH groups, and the difference was not statistically significant. No clear relationship was found between completion of RH and pelvic control or morbidity. Although urinary complications including bladder dysfunction and fistulae were unique to the completed RH group, radiation-related complications such as radiation cystitis, radiation proctitis, and bone necrosis were seen primarily in the aborted RH group. Conclusions. Given the lack of significant difference in survival, further studies are needed to evaluate the impact of completing versus aborting RH on pelvic control and morbidity to reach a definitive conclusion.
引用
收藏
页码:374 / 381
页数:8
相关论文
共 34 条
[1]   IDENTIFICATION OF PROGNOSTIC FACTORS AND RISK GROUPS IN PATIENTS FOUND TO HAVE NODAL METASTASIS AT THE TIME OF RADICAL HYSTERECTOMY FOR EARLY-STAGE SQUAMOUS CARCINOMA OF THE CERVIX [J].
ALVAREZ, RD ;
SOONG, SJ ;
KINNEY, WK ;
REID, GC ;
SCHRAY, MF ;
PODRATZ, KC ;
MORLEY, GW ;
SHINGLETON, HM .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :130-135
[2]  
[Anonymous], 2009, SEER Cancer Statistics Review, 1975-2006
[3]   Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma [J].
Azria, E ;
Morice, P ;
Haie-Meder, C ;
Thoury, A ;
Pautier, P ;
Lhomme, C ;
Duvillard, P ;
Castaigne, D .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (04) :332-337
[4]   LONG-TERM EFFECTS ON BLADDER FUNCTION FOLLOWING RADICAL HYSTERECTOMY WITH AND WITHOUT POSTOPERATIVE RADIATION [J].
BANDY, LC ;
CLARKEPEARSON, DL ;
SOPER, JT ;
MUTCH, DG ;
MACMILLAN, J ;
CREASMAN, WT .
GYNECOLOGIC ONCOLOGY, 1987, 26 (02) :160-168
[5]   COMPLICATIONS OF COMBINED RADICAL HYSTERECTOMY POSTOPERATIVE RADIATION-THERAPY IN WOMEN WITH EARLY STAGE CERVICAL-CANCER [J].
BARTER, JF ;
SOONG, SJ ;
SHINGLETON, HM ;
HATCH, KD ;
ORR, JW .
GYNECOLOGIC ONCOLOGY, 1989, 32 (03) :292-296
[6]   Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls [J].
Bergmark, K. ;
Avall-Lundqvist, E. ;
Dickman, P. W. ;
Henningsohn, L. ;
Steineck, G. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) :1130-1139
[7]  
Bortolozzi G, 1983, Eur J Gynaecol Oncol, V4, P9
[8]   EARLY STAGE CERVICAL-CANCER - ABORTED VERSUS COMPLETED RADICAL HYSTERECTOMY [J].
BREMER, GL ;
VANDERPUTTEN, HWHM ;
DUNSELMAN, GAJ ;
DEHAAN, J .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1992, 47 (02) :147-151
[9]  
Cosin JA, 1998, CANCER, V82, P2241, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2241::AID-CNCR20>3.0.CO
[10]  
2-T